Mammary Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
In this study, VEGFR3 and Ki67 expression but not mammaglobin-A correlated with breast tumour pathology.
|
31263371 |
2019 |
Mammary Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Here we evaluated the use of adoptively transferred Mammaglobin-A specific CD8 T cells in combination with low dose irradiation to induce breast tumor rejection and prevent relapse.
|
22911764 |
2012 |
Mammary Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
The secretoglobin mammaglobin 1 (MGB1) is strongly expressed in breast tumours, and is therefore used to detect breast cancer metastases, although it has also been detected in other tissues.
|
22994369 |
2012 |
Mammary Neoplasms
|
0.100 |
Biomarker
|
group |
LHGDN |
Prognostic value of the molecular detection of circulating tumor cells using a multimarker reverse transcription-PCR assay for cytokeratin 19, mammaglobin A, and HER2 in early breast cancer.
|
18451221 |
2008 |
Mammary Neoplasms
|
0.100 |
AlteredExpression
|
group |
LHGDN |
Detection of mammaglobin mRNA in peripheral blood is associated with high grade breast cancer: interim results of a prospective cohort study.
|
18289390 |
2008 |
Mammary Neoplasms
|
0.100 |
Biomarker
|
group |
LHGDN |
Assessment of RT-PCR detection of human mammaglobin for the diagnosis of breast cancer derived pleural effusions.
|
18303409 |
2008 |
Mammary Neoplasms
|
0.100 |
AlteredExpression
|
group |
LHGDN |
Mammaglobin and lipophilin B expression in breast tumors and their lack of effect on breast cancer cell proliferation.
|
18630503 |
2008 |
Mammary Neoplasms
|
0.100 |
Biomarker
|
group |
LHGDN |
Breast-specific expression of MGB1/mammaglobin: an examination of 480 tumors from various organs and clinicopathological analysis of MGB1-positive breast cancers.
|
17192791 |
2007 |
Mammary Neoplasms
|
0.100 |
Biomarker
|
group |
LHGDN |
Correlation between molecular metastases in sentinel lymph nodes of breast cancer patients and St Gallen risk category.
|
17071045 |
2007 |
Mammary Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
In breast tissue, mammaglobin A expression was down-regulated in 49% and up-regulated in 12% of breast tumor specimens compared with matching normal tissues, while lipophilin B was down-regulated in 59% and up-regulated in 3% of cases.
|
16603086 |
2006 |
Mammary Neoplasms
|
0.100 |
Biomarker
|
group |
LHGDN |
Detection of Mammaglobin A-mRNA-positive circulating tumor cells in peripheral blood of patients with operable breast cancer with nested RT-PCR.
|
16925986 |
2006 |
Mammary Neoplasms
|
0.100 |
AlteredExpression
|
group |
LHGDN |
Detection and quantification of mammaglobin in the blood of breast cancer patients: can it be useful as a potential clinical marker? Preliminary results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study.
|
16760290 |
2006 |
Mammary Neoplasms
|
0.100 |
AlteredExpression
|
group |
LHGDN |
Relationship between human mammaglobin mRNA expression in breast cancer tissue and clinico-pathologic features of the tumors.
|
16761620 |
2006 |
Mammary Neoplasms
|
0.100 |
AlteredExpression
|
group |
LHGDN |
Mammaglobin as molecular marker of breast cancer (micro)metastases.
|
16203799 |
2005 |
Mammary Neoplasms
|
0.100 |
AlteredExpression
|
group |
LHGDN |
Human mammaglobin mRNA is a reliable molecular marker for detecting occult breast cancer cells in peripheral blood.
|
16110760 |
2005 |
Mammary Neoplasms
|
0.100 |
Biomarker
|
group |
LHGDN |
Mammaglobin a in breast cancer: existence of multiple molecular forms.
|
15609337 |
2005 |
Mammary Neoplasms
|
0.100 |
AlteredExpression
|
group |
LHGDN |
Mammaglobin expression in leukapheresis products is a predictive marker of poor prognosis in women with high-risk breast cancer.
|
15447988 |
2004 |
Mammary Neoplasms
|
0.100 |
AlteredExpression
|
group |
LHGDN |
Highly sensitive detection of the MGB1 transcript (mammaglobin) in the peripheral blood of breast cancer patients.
|
14696125 |
2004 |
Mammary Neoplasms
|
0.100 |
Biomarker
|
group |
LHGDN |
RT-PCR for mammaglobin genes, MGB1 and MGB2, identifies breast cancer micrometastases in sentinel lymph nodes.
|
15151203 |
2004 |
Mammary Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Expression of secretoglobin family 2A member 2 (SCGB2A2, also known as mammaglobin-1) has been detected in a high percentage of primary and metastatic breast tumors, to a lesser extent in normal breast, but not in other normal tissues.
|
15451460 |
2004 |
Mammary Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Response of established human breast tumors to vaccination with mammaglobin-A cDNA.
|
15367572 |
2004 |
Mammary Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
We evaluated SCGB2A2 expression at the mRNA and at the protein level by reverse-transcription polymerase chain reaction and immunocytochemistry in 52 and 32 breast tumors, respectively.
|
14515009 |
2003 |
Mammary Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Mammaglobin, a promising diagnostic marker for breast cancer, forms a covalent complex with lipophilin B. mRNA levels for each component of the complex were determined for a number of breast tumors and normal tissues, and correlation of message expression was highly significant between mammaglobin and lipophilin B (p < 0.0001).
|
12022875 |
2002 |